GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » Total Stockholders Equity

Imricor Medical Systems (ASX:IMR) Total Stockholders Equity : A$-13.08 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems Total Stockholders Equity?

Imricor Medical Systems's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$-13.08 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Imricor Medical Systems's Book Value per Share for the quarter that ended in Dec. 2023 was A$-0.07. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Imricor Medical Systems's Debt-to-Equity for the quarter that ended in Dec. 2023 was -1.19.


Imricor Medical Systems Total Stockholders Equity Historical Data

The historical data trend for Imricor Medical Systems's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems Total Stockholders Equity Chart

Imricor Medical Systems Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial 10.21 38.27 31.32 11.13 -13.08

Imricor Medical Systems Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 31.32 18.63 11.13 -1.28 -13.08

Imricor Medical Systems  (ASX:IMR) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Imricor Medical Systems's Book Value per Share for the quarter that ended in Dec. 2023 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Imricor Medical Systems's Debt-to-Equity for the quarter that ended in Dec. 2023 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Imricor Medical Systems Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Imricor Medical Systems (ASX:IMR) Business Description

Traded in Other Exchanges
N/A
Address
400 Gateway Boulevard, Burnsville, MN, USA, 55337
Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems (ASX:IMR) Headlines

No Headlines